If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWest.brom 6.15% Regulatory News (WBS)

  • There is currently no data for WBS

Profit Participating Deferred Shares

19 Jan 2018 15:18

RNS Number : 4369C
West Bromwich Building Society
19 January 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OR ITS TERRITORIES, AUSTRALIA, SOUTH AFRICA, JAPAN OR CANADA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE LAWS OF SUCH JURISDICTION

Regulatory News Announcement

For Immediate Release19 January 2018

West Bromwich Building Society

variations to the conditions of the profit participating deferred shares

On 13 December 2017, West Bromwich Building Society (the "Society") announced plans for a liability management exercise (the "LME") in relation to its 3,650 Profit Participating Deferred Shares (the "PPDS") and its £75 million 6.15 per cent. Permanent Interest Bearing Shares (the "PIBS").

The Society announced that, as part of the LME, it expected to propose resolutions to the holders of the PPDS to vary the Special Conditions of Issue of the PPDS (the "PPDS Conditions") in certain respects (the "Variations"). The Society announced that it expected to make certain of these Variations in the near-term, in particular those Variations which address the investor challenge as to qualification of the PPDS as common equity tier 1 capital.

On 10 January 2018, the Society wrote to the holders of the PPDS, inviting them to approve written resolutions authorising the Society to make certain Variations. On 18 January 2018, these written resolutions were passed with the consent in writing of the holders of more than three-quarters of the PPDS. The Society has, therefore, varied the PPDS Conditions with effect from today, and the revised PPDS Conditions are available for viewing on the Society's website.

The Society is making good progress in its preparations for the LME, and will continue to work towards launching the LME as soon as reasonably practicable, targeting the first half of 2018.

Enquiries

Andy Donald

Maitland

+44 (0) 20 7379 5151

adonald@maitland.co.uk

DISCLAIMER

Neither this announcement, the publication in which it is contained nor any copy of it may be made or transmitted into the United States of America (including its territories or possessions, any state of the United States of America and the District of Columbia) (the "United States") nor taken, transmitted or distributed, directly or indirectly, into Australia, South Africa, Japan or Canada or any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. Any failure to comply with this restriction may constitute a violation of securities law in those jurisdictions. The distribution of this document in other jurisdictions may also be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

None of the securities referred to herein have been, or will be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), and they may not be offered or sold in the United States absent an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CARBUGDBUBBBGIC
Date   Source Headline
13th Feb 20261:08 pmRNSNOTICE OF REDEMPTION OF SECURITIES
27th Nov 20258:00 amRNSHalf-year Financial Report
23rd Sep 20257:00 amRNSAnnouncement to Listing Authorities
29th May 20258:00 amRNSAnnual Financial Report
15th May 20257:00 amRNSDirectorate Change
25th Mar 20251:46 pmRNSPIBS Announcement
28th Nov 20248:00 amRNSHalf-Year/Interim Report
25th Sep 20242:10 pmRNSAnnouncement to Listing Authorities
16th Aug 20249:53 amRNSAnnouncement to Listing Authorities
6th Aug 20249:51 amRNSAnnouncement to Listing Authorities
31st May 20247:58 amRNSFinal Results
25th Mar 202412:09 pmRNSAnnouncement to Listing Authorities
30th Nov 20238:00 amRNSHalf-year results for the six months to 30 Sept 23
12th Sep 202312:56 pmRNSAnnouncement to Listing Authorities
1st Aug 20232:14 pmRNSAppointment of Non Executive Director
17th Jul 202311:59 amRNSPARTIAL REPURCHASE OF NOTES - REPLACEMENT
17th Jul 202311:16 amRNSPARTIAL REPURCHASE OF SUBORDINATED FIXED RATE NOTE
26th Jun 20233:54 pmRNSStatement re (add text)
1st Jun 20238:00 amRNSFinal Results
15th May 20232:18 pmRNSNotice of Optional Redemption
13th Mar 20233:02 pmRNSAnnouncement to Listing Authorities
7th Dec 20224:21 pmRNSDirectorate Change
7th Dec 20224:05 pmRNSHalf-year Report
7th Sep 20223:56 pmRNSAnnouncement to Listing Authorities
26th May 20227:30 amRNSFinal Results
26th May 20227:30 amRNSDirectorate Change
9th Mar 20223:32 pmRNSPIBS Interest Payment
24th Nov 20213:04 pmRNSHalf-year Report
24th Nov 20213:03 pmRNSDistribution Announcement CCDS
30th Sep 20219:15 amRNSCancellation of Interest Payments
28th Jul 20213:43 pmRNSDirectorate Change
27th May 20219:07 amRNSDistribution Announcement CCDS
27th May 20218:55 amRNSFinal Results
26th May 20212:03 pmRNSDirectorate Change
18th Mar 20218:44 amRNSCancellation of interest payments
5th Mar 20217:00 amRNSDirectorate Change
30th Dec 202011:46 amRNSBoard Change
26th Nov 20203:29 pmRNSDistribution Announcement CCDS
26th Nov 20203:21 pmRNSHalf-year Report
1st Oct 202010:15 amRNSCancellation of Interest Payments
22nd Jul 20204:06 pmRNSPIBS buy back and cancellation
2nd Jun 20202:16 pmRNSFinal Results
26th Mar 20209:20 amRNSCancellation of Interest Payments
20th Jan 20204:19 pmRNSUpdate on PIBS Distribution Policy
26th Nov 20191:27 pmRNSHalf-year Report
2nd Oct 20192:58 pmRNSCancellation of Interest Payments
29th May 20193:21 pmRNSFinal Results
29th Mar 20192:30 pmRNSCancellation of Interest Payments
6th Dec 20182:34 pmRNSHalf-year Report
26th Sep 20184:51 pmRNSCancellation of Interest Payment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.